Tests:Cholesterol-HDL Ratio, Plasma: Difference between revisions
Tests:Cholesterol-HDL Ratio, Plasma
No edit summary |
No edit summary |
||
| Line 4: | Line 4: | ||
{| class="wikitable" | {| class="wikitable" | ||
! colspan="2" | | ! colspan="2" | | ||
== | == Overview == | ||
|- | |- | ||
|Department | |Department | ||
| Line 14: | Line 14: | ||
|Synonyms | |Synonyms | ||
|Lipid profile | |Lipid profile | ||
|- | |||
|Test Availabilty | |||
|Monday - Sunday, testing routinely available out of hours | |||
|- | |- | ||
|Turnaround Time | |Turnaround Time | ||
| Line 22: | Line 25: | ||
|- | |- | ||
! colspan="2" | | ! colspan="2" | | ||
== | == Specimen Requirements == | ||
|- | |- | ||
|Specimen Type | |Specimen Type | ||
| Line 33: | Line 36: | ||
|Acceptable | |Acceptable | ||
|4 mL Li-Hep <span style="background:#3cb371"> Green-Top </span> | |4 mL Li-Hep <span style="background:#3cb371"> Green-Top </span> | ||
|- | |||
|Unacceptable | |||
| | |||
|- | |- | ||
|Specimen Transportation | |Specimen Transportation | ||
| | | | ||
|- | |- | ||
| | |Paediatric Requirements | ||
|600 µL <span style="background:#99e6b3"> Li-Hep Microtainer </span> | |600 µL <span style="background:#99e6b3"> Li-Hep Microtainer </span> | ||
|- | |- | ||
! colspan="2" | | ! colspan="2" | | ||
== | == Aliquot Requirements == | ||
|- | |- | ||
|Sample Type | |Sample Type | ||
| | |||
|- | |||
|Preferred Volume | |||
| | | | ||
|- | |- | ||
| Line 53: | Line 62: | ||
|- | |- | ||
! colspan="2" | | ! colspan="2" | | ||
== | == Clinical Information == | ||
|- | |- | ||
|Reference Intervals | |Reference Intervals | ||
| Line 68: | Line 77: | ||
|- | |- | ||
! colspan="2" | | ! colspan="2" | | ||
== | == Comments == | ||
|- | |- | ||
| colspan="2" |Help for Lipid Studies Interpretation | | colspan="2" |''Help for Lipid Studies Interpretation'' | ||
Reported Comments: | Reported Comments: | ||
1. All reports get this comment (see below for additional information on optimal | 1. All reports get this comment (see below for additional information on optimal levels): | ||
levels) | |||
" | "Optimal levels are suggested by the New Zealand Guidelines Group though an individualised multi-factorial approach is preferred." | ||
2. All reports get this comment, unless superseded by anyone or more of the other comments below: | |||
greater than | "Cardiovascular risk should be addressed by lifestyle and pharmacological interventions in subjects with 5-year CV risk greater than 15%." | ||
3. Total | 3. Total cholesterol >8 mmol/L or Total cholesterol/HDL ratio >8: | ||
|} | |} | ||